Taisho Pharmaceutical Launches Lusefi – A Newly Approved Oral Anti-Diabetic Drug For Type 2 Diabetes
Lusefi®, an oral anti-diabetic for type 2 diabetes mellitus which has just been launched by Taisho Pharmaceutical is expected to provide adequate glycaemic control, which lowers blood glucose and serve…